EMILY BROWN: Open Payments
NPI 1609563063 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 27 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $827 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 5 | $179 |
| Ardelyx, Inc. | 5 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| ABBVIE INC. | 5 | $95 |
| GENZYME CORPORATION | 3 | $90 |
| Janssen Biotech, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $19 |
Products named: DUPIXENT, ZENPEP, IBSRELA, TREMFYA, CREON, ENTYVIO, SKYRIZI, OMVOH.
Industry payments across SC — which companies pay providers there.
